What is Zacks Research's Estimate for Perrigo Q2 Earnings?

Perrigo Company plc (NYSE:PRGO - Free Report) - Analysts at Zacks Research decreased their Q2 2025 EPS estimates for Perrigo in a research note issued to investors on Wednesday, May 28th. Zacks Research analyst S. Ganoria now anticipates that the company will earn $0.60 per share for the quarter, down from their previous forecast of $0.70. The consensus estimate for Perrigo's current full-year earnings is $2.56 per share. Zacks Research also issued estimates for Perrigo's Q4 2025 earnings at $0.99 EPS, Q2 2026 earnings at $0.80 EPS, Q1 2027 earnings at $0.62 EPS and FY2027 earnings at $3.54 EPS.

Separately, Wall Street Zen upgraded shares of Perrigo from a "hold" rating to a "buy" rating in a research report on Saturday, May 24th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Perrigo presently has a consensus rating of "Hold" and a consensus target price of $33.00.

Perrigo Stock Performance

Shares of Perrigo stock traded down $0.32 during trading hours on Friday, reaching $26.81. The company's stock had a trading volume of 1,041,776 shares, compared to its average volume of 1,508,477. The company's 50 day simple moving average is $26.10 and its 200 day simple moving average is $26.19. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. Perrigo has a one year low of $23.14 and a one year high of $30.93. The stock has a market cap of $3.69 billion, a P/E ratio of -22.91 and a beta of 0.45.

Perrigo (NYSE:PRGO - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.04. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the prior year, the firm earned $0.29 earnings per share. The business's quarterly revenue was down 3.5% compared to the same quarter last year.

Hedge Funds Weigh In On Perrigo

Several large investors have recently bought and sold shares of the stock. Price T Rowe Associates Inc. MD increased its stake in Perrigo by 41.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 11,073,026 shares of the company's stock valued at $310,488,000 after buying an additional 3,227,487 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Perrigo by 2.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 7,135,741 shares of the company's stock worth $200,085,000 after purchasing an additional 146,211 shares during the last quarter. Deprince Race & Zollo Inc. grew its stake in shares of Perrigo by 1.1% in the 4th quarter. Deprince Race & Zollo Inc. now owns 4,557,844 shares of the company's stock worth $117,182,000 after purchasing an additional 50,728 shares during the last quarter. Cooke & Bieler LP grew its stake in shares of Perrigo by 4.1% in the 4th quarter. Cooke & Bieler LP now owns 3,573,651 shares of the company's stock worth $91,879,000 after purchasing an additional 139,650 shares during the last quarter. Finally, Sound Shore Management Inc. CT grew its stake in shares of Perrigo by 23.1% in the 1st quarter. Sound Shore Management Inc. CT now owns 3,285,167 shares of the company's stock worth $92,116,000 after purchasing an additional 616,387 shares during the last quarter. Institutional investors and hedge funds own 95.91% of the company's stock.

Insider Activity at Perrigo

In related news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the sale, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. This trade represents a 18.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.70% of the stock is currently owned by insiders.

Perrigo Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Friday, May 30th will be given a $0.29 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $1.16 annualized dividend and a yield of 4.33%. Perrigo's dividend payout ratio is presently -88.55%.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.